TITLE

Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis

AUTHOR(S)
Menon, Vimala; Mehrotra, Abhas; Saxena, Rohit; Jaffery, Nargis F.
PUB. DATE
September 2007
SOURCE
Indian Journal of Ophthalmology;Sep2007, Vol. 55 Issue 5, p355
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
Aim: To compare the efficacy of intravenous methylprednisolone and intravenous dexamethasone on visual recovery and evaluate their side-effects for the treatment of optic neuritis.Materials and Methods: Prospective, randomized case-controlled study including 21 patients of acute optic neuritis presenting within eight days of onset and with visual acuity less then 20/60 in the affected eye who were randomly divided into two groups. Group I received intravenous dexamethasone 200 mg once daily for three days and Group II received intravenous methylprednisolone 250 mg/six-hourly for three days followed by oral prednisolone for 11 days. Parameters tested were pupillary reactions, visual acuity, fundus findings, color vision, contrast sensitivity, Goldmann visual fields and biochemical investigations for all patients at presentation and follow-up.Results: Both groups were age and sex-matched. LOGMAR visual acuity at presentation was 1.10 +/- 0.52 in Group I and 1.52 +/- 0.43 in Group II. On day 90 of steroid therapy, visual acuity improved to 0.28 +/- 0.33 in Group I and 0.36 +/- 0.41 in Group II ( P =0.59). At three months there was no statistically significant difference in the color vision, contrast sensitivity, stereoacuity, Goldman fields and the amplitude and latency of visually evoked response between the two groups. The concentration of vitamin C, glucose, sodium, potassium, urea and creatinine were within the reported normal limits.Conclusion: Intravenous dexamethasone is an effective treatment for optic neuritis. However, larger studies are required to establish it as a safe, inexpensive and effective modality for the treatment of optic neuritis.
ACCESSION #
26201076

 

Related Articles

  • Steroid-sparing effect of pimecrolimus cream 1% in children with severe atopic dermatitis. Zuberbier, Torsten; Heinzerling, Lucie; Bieber, Thomas; Schauer, Uwe; Klebs, Sven; Bräutigam, Matthias; Bräutigam, Matthias // Dermatology (10188665);Dec2007, Vol. 215 Issue 4, p325 

    Objective: To investigate if pimecrolimus cream 1% reduces the need for steroids in the long-term management of severe pediatric atopic dermatitis (AD).Methods: A total of 184 pediatric patients (aged 2-17 years) with a history of severe AD according to Rajka and...

  • Combination Therapy of Etanercept and Fumarates versus Etanercept Monotherapy in Psoriasis: A Randomized Exploratory Study. van Bezooijen, Ji Sun; Balak, Deepak M.W.; van Doorn, Martijn B.a.; Looman, Caspar W.N.; Schreurs, Marco W.J.; Koch, Birgit C.P.; van Gelder, Teun; Prens, Errol P. // Dermatology (10188665);Sep2016, Vol. 232 Issue 4, p407 

    Background: Biologics are a safe and efficacious therapy for psoriasis. The drug survival of biologics may be disappointing, primarily due to loss of efficacy. Therefore, safe combination treatments are sought to improve their clinical response.Objective: To assess the...

  • Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. Oranje, Arnold P.; Chosidow, Olivier; Sacchidanand, Sarvajnamurthy; Todd, Gail; Singh, Krishan; Scangarella, Nicole; Shawar, Ribhi; Twynholm, Monique; TOC100224 Study Team // Dermatology (10188665);Dec2007, Vol. 215 Issue 4, p331 

    Background: Retapamulin is a novel pleuromutilin antibacterial developed for topical use. Objective: To compare the efficacy and safety of retapamulin ointment, 1% (twice daily for 5 days), with sodium fusidate ointment, 2% (3 times daily for 7 days), in impetigo....

  • Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning. Shukla, Manoj; Shikoh, Imran; Saleem, Akbar // Indian Journal of Ophthalmology;Mar2006, Vol. 54 Issue 1, p68 

    A letter to the editor about salvaging vision in methyl alcohol poisoning through the use of Intravenous methylprednisolone.

  • Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. Groopman, Jerome E.; Gottlieb, Michael S.; Goodman, Jesse; Mitsuyasu, Ronald T.; Conant, Marcus A.; Prince, Harry; Fahey, John L.; Derezin, Marvin; Weinstein, Wilfred M.; Casavante, Conrad; Rothman, John; Rudnick, Seth A.; Volberding, Paul A.; Groopman, J E; Gottlieb, M S; Goodman, J; Mitsuyasu, R T; Conant, M A; Prince, H; Fahey, J L // Annals of Internal Medicine;May84, Vol. 100 Issue 5, p671 

    In a randomized prospective study we tested the toxicity and efficacy of recombinant alpha-2 interferon in the treatment of Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. High doses (50 X 10(6) U/m2 body surface area, intravenously) or low doses (1 X 10(6) U/m2,...

  • Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial. Campanati, anna; Giannoni, Melania; Scalise, alessandro; De Blasio, Simona; Giuliano, angela; Giuliodori, Katia; Ganzetti, Giulia; Bolletta, Elisa; Di Benedetto, Giovanni; Offidani, annamaria // Dermatology (10188665);Sep2016, Vol. 232 Issue 4, p478 

    Background/objective: This study aims at the evaluation of the efficacy and safety of a combination therapy based on pidobenzone 4% and fractional CO2 laser or cryotherapy in the treatment of solar lentigines and the prevention of eventual posttreatment hyperchromia.Methods:...

  • Optimal haloperidol dosage in first-episode psychosis. Zhang-Wong, J; Zipurskcy, RB; Beiser, M; Bean, G; Zipursky, R B // Canadian Journal of Psychiatry;Mar1999, Vol. 44 Issue 2, p164 

    Objective: To determine optimal doses of haloperidol for the treatment of a first episode of psychosis.Method: A 4-week prospective controlled clinical trial with "optimal dose" defined as the dose at which either of the following occurs: 1) significant improvement,...

  • Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss. Yoo, Myung Hoon; Lim, Won Sub; Park, Joo Hyun; Kwon, Joong Keun; Lee, Tae-Hoon; an, Yong-Hwi; Kim, Young-Jin; Kim, Jong Yang; Lim, Hyun Woo; Park, Hong Ju // Audiology & Neuro-Otology;May2017, Vol. 21 Issue 6, p399 

    Objectives: Severe-to-profound sudden sensorineural hearing loss (SSNHL) has a poor prognosis. We aimed to compare the efficacy of simultaneous and sequential oral and intratympanic steroids for this condition.Methods: Fifty patients with severe-to-profound SSNHL (>70...

  • Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study. Francobandiera, Giorgio; Francobandiera, G // Canadian Journal of Psychiatry;May2001, Vol. 46 Issue 4, p356 

    Objective: This study evaluates the clinical response to olanzapine used in association with selective serotonin reuptake inhibitors (SSRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD). Methods: We describe the cases of 9 patients with...

  • Delirium in psychiatric inpatients: a case-control study. Patten, Scott B; Patten, S B; Williams, J V; Petcu, R; Oldfield, R // Canadian Journal of Psychiatry;Mar2001, Vol. 46 Issue 2, p162 

    Objective: To investigate the clinical and pharmacoepidemiological determinants of delirium in a psychiatric inpatient population.Method: A case-control study design was used. Potential cases and potential controls were identified using hospital discharge data. The...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics